According to Rossi et al., the combination of a peptide-based cancer vaccine with STING treatment enhanced the therapeutic effects of immunization, resulting in prolonged control and slower growth of B16-OVA and TC-1 tumors in mice [171]. This evidence concerns the gene STING1 and cancer.